mammoth-biosciences
(2)
Trevor Martin
Trevor Martin is the co-founder and CEO of Mammoth Biosciences, the CRISPR company he built alongside Nobel laureate Jennifer Doudna and two of her graduate students. A Princeton-trained computational biologist who earned his PhD at Stanford, Martin turned a cold email to Doudna into a $465M-funded platform company developing ultracompact CRISPR systems - including NanoCas, the first efficient extrahepatic gene editor - aimed at permanently curing genetic diseases.
Tom Cahill
Thomas J. Cahill, MD, PhD is the founder and managing partner of Newpath Partners, a Boston-based life sciences venture firm he built from the ground up to translate breakthrough academic science into medicines. A structural biologist trained under two Nobel laureates, Cahill has co-founded more than a dozen biotech companies — including Prime Medicine, Chroma Medicine, and Autobahn Therapeutics — and became one of the pandemic's most consequential behind-the-scenes operators when he assembled Scientists to Stop COVID-19, a coalition that fed curated research directly to the White House and helped redirect Regeneron's manufacturing to Dublin.